Global biopharmaceutical Market: to expand to US $600 billion in the next seven years

Source: Bio exploration 2015-9-28 market analysis: the market size is expected to reach 608.6 billion US dollars by 2020 According to the report of grand view research, in 2013, the global market size of biotechnology is 270.5 billion US dollars Based on the diagnosis and treatment of diseases, the restructuring technology, medical biotechnology and DNA are also needed The demand for sequencing technology is increasing The global biotechnology market is expected to grow at a compound annual growth rate of 12.3% By 2020, the global biotechnology market will reach US $606.8 billion The increasing prevalence of increasingly popular diseases such as cancer, hepatitis B and other rare diseases is the biggest factor to promote the development of biotechnology market Secondly, with the development of the economy, the government's support for the market is also an important factor to promote its development In addition, some organizations, such as DBT, other government funded organizations, such as nbtb and biotechnology industry representative organizations, will support the development of biotechnology market in the next few years With the continuous growth of population bases in the United States, China and India, the growth of demand for wheat, rice, sugarcane, beans and other food products as well as agricultural development has a great impact on the growth of biotechnology market The limitation of agricultural land, the shortage of water resources, the low yield of crops and the attack of pests promote researchers to develop and innovate agricultural technology The application of biotechnology such as transgenic crops is also the main driving force of market growth Technical analysis: rapid development of tissue regeneration technology and DNA sequencing technology biotechnology mainly includes fermentation, tissue regeneration technology, PCR technology, DNA sequencing, chromatography, single cell analysis, etc In 2013, tissue regeneration technology dominated the market, with revenue of US $87.92 billion However, due to the rapid innovation and development of pharmaceutical companies and biotechnology companies, DNA sequencing and single cell analysis technology are expected to have considerable growth in the next few years In recent years, tissue regeneration technology has been widely used in the treatment of various diseases It is used to repair the cells and organs that lose function due to burn, aging, diabetes, ulcer or congenital abnormality The incidence rate of Parkinson's disease and Alzheimer's disease has promoted the application of tissue regeneration technology In recent years, the rapid prevalence of diabetes has further promoted the development of tissue regeneration technology DNA sequencing is expected to grow at a compound annual growth rate of 18.1%, widely used in agriculture, biology, medicine and geology With the reduction of DNA sequencing cost, the breakthrough of PCR technology, nanotechnology and bioinformatics technology, it is expected to promote the development of the market Application Analysis: biopharmaceuticals dominate the whole market, while recombinant proteins dominate the whole biopharmaceutical market Global biotechnology can be divided into biopharmaceuticals, bio services, bio agriculture and bio industry Biopharmaceuticals, including the manufacture of advanced drugs, orphan drugs, monoclonal antibodies and recombinant proteins, account for the main share of the biotechnology application market, with a market value of US $184.21 billion in 2013 Based on the development of recombinant protein vaccine, recombinant protein is expected to dominate the whole biopharmaceutical market in the next few years Due to the continuous improvement of clinical research initiative of pharmaceutical companies and biotechnology companies, the market profit of biological services will be very rich by 2020 The increasing demand for biotechnology, the decreasing cost, the increasingly strict regulations and the increasing complexity of biotechnology technology will promote the market development of biological services Regional analysis: seven years later, the market share of Asia Pacific region accounts for one quarter of the global biotechnology market, which is divided into North America, Europe, Latin America, Asia Pacific region, etc North America has the largest market share, accounting for 42.3%, thanks to the growing number of pharmaceutical companies and R & D projects in the region It is estimated that by 2020, the market size of the Asia Pacific region will reach US $145.9 billion The increasing awareness of the introduction of health care is a huge driving force for the development of the region Competition analysis: cooperation, M & A and R & D outsourcing are the key strategies for enterprises to increase market share The global biotechnology market is essentially unified The world's leading biotech companies are Amgen, Novo Nordisk, TIWA pharmaceutical, regenerant, Roche, Alkermes and Cubist pharmaceuticals Roche accounted for 17.1% of the total market share in 2013 The key strategies for these enterprises to increase market share include strategic cooperation, M & A, R & D outsourcing and manufacturing Sanofi Aventis, for example, worked with transgene, Bristol Myers Squibb and Joslin Diabetes Centerfor to develop immunotherapy and diabetes products In order to increase its market share in Latin America, Sanofi Aventis acquired genfar, a leading pharmaceutical company in Colombia, and plurome to expand its business in biosurgery.